Vanguard Fiduciary Trust
INAB icon

Vanguard Fiduciary Trust’s IN8bio INAB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Hold
43,570
– – ﹤0.01% 3821
2026
Q1 		$64.7K Buy
+43,570
New +$84.3K ﹤0.01% 3783

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Vanguard Fiduciary Trust's INAB Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its IN8bio (INAB) position steady in Q2 2026 at 43,570 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #3821.

Vanguard Fiduciary Trust first reported a position in INAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $64.7K in Q1 2026. 21 funds tracked by Wall St. Rank hold INAB as of Q2 2026.

  • Vanguard Fiduciary Trust held 43,570 shares of IN8bio worth $62K as of Q2 2026.
  • Vanguard Fiduciary Trust left its IN8bio share count unchanged in Q2 2026.
  • IN8bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3821 holding.
  • Vanguard Fiduciary Trust first reported a position in IN8bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's IN8bio position peaked at $64.7K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held IN8bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.